Concepedia

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer

Naiyarat Prasongsook, Aditi Kumar, Ashish V. Chintakuntlawar, Robert L. Foote, Jan L. Kasperbauer, Julian R. Molina, Yolanda I. Garces, Michelle A. Neben Wittich, Joseph Rubin, Ronald L. Richardson,

The Journal of Clinical Endocrinology & Metabolism · 2017 · 124 citations · 25 references

DOIFull text

Open access

Abstract

MMT appears to convey longer survival in ATC among patients with stage IVA/B disease.

References

25

Anaplastic thyroid carcinoma: A 50-year experience at a single institution

Bryan McIver, Ian Hay, Dario Giuffrida et al. · Surgery · 2001 · 483 citations

, , +1

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

Katsutaro Shimaoka, David Schoenfeld, William D. DeWys et al. · Cancer · 1985 · 461 citations · Full text

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer

Marcia Ryder, Ronald A. Ghossein, Julio C. Ricarte‐Filho et al. · Endocrine Related Cancer · 2008 · 450 citations · Full text

, , +14

Treatment of Anaplastic Thyroid Carcinoma with Paclitaxel: Phase 2 Trial Using Ninety-Six-hour Infusion

Kenneth B. Ain, Merrill J. Egorin, Philip A. DeSimone · Thyroid · 2000 · 297 citations

Prognostic Factors and Treatment Outcomes for Anaplastic Thyroid Carcinoma: ATC Research Consortium of Japan Cohort Study of 677 Patients

Iwao Sugitani, Akira Miyauchi, Kiminori Sugino et al. · World Journal of Surgery · 2012 · 261 citations